EDESA BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
EDESA BIOTECH, INC. (EDSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $9.59 for the 9-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2017-12-01
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-09-30 was 8.99 CAD.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-06-30 was -10.35 CAD.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-03-31 was 0.00 CAD.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-12-31 was 11.50 CAD.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was 10.14 CAD, a 26.31% decline from fiscal 2014.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was 13.76 CAD, a 106.30% increase from fiscal 2013.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was 6.67 CAD.
CAD
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|---|---|
| 2015-09-30 | 8.99 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -1.36 CAD derived: sum of 2 quarters · filed 2015-12-14 | -1.36 CAD derived: sum of 3 quarters · filed 2016-05-09 | 10.14 CAD 10-K · filed 2015-12-14 | ||
| 2015-06-30 | -10.35 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | -10.35 CAD derived: sum of 2 quarters · filed 2016-05-09 | 1.15 CAD 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | 0.00 CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | 11.50 CAD 10-Q · filed 2016-05-09 | 1.15 CAD 10-Q · filed 2015-05-11 | |||
| 2014-12-31 | 11.50 CAD 10-Q · filed 2016-02-08 | |||||
| 2014-09-30 | 17.40 CAD 10-K · filed 2015-12-14 | |||||
| 2014-08-31 | 13.76 CAD 10-K · filed 2015-12-14 | |||||
| 2014-06-30 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | 1.32 CAD 10-Q · filed 2015-08-10 | ||||
| 2014-03-31 | 1.32 CAD 10-Q · filed 2015-05-11 | |||||
| 2013-08-31 | 6.67 CAD 10-K · filed 2015-12-14 |
USD
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 1 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|
| 2016-06-30 | $9.59 10-Q · filed 2016-08-09 | |||||
| 2015-09-30 | $8.28 10-K · filed 2017-12-01 | |||||
| 2014-12-31 | $1.15 10-Q · filed 2015-02-09 | |||||
| 2014-09-30 | $15.99 10-K · filed 2016-12-14 | $1.74 10-Q · filed 2015-02-09 | ||||
| 2014-08-31 | $12.78 10-K · filed 2016-12-14 | $1.38 10-K · filed 2014-11-21 | ||||
| 2013-12-31 | $1.55 10-Q · filed 2015-02-09 | |||||
| 2013-08-31 | $0.67 10-K · filed 2014-11-21 | |||||
| 2012-08-31 | $0.05 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |